With more studies emerging, GLP-1 and dual GIP/GLP-1 medications have become well-established options for those with obesity ...

University Hospitals cardiologist explains the benefits, side effects, and future of these increasingly popular drugs.

Medicines for obesity, diabetes, rare diseases, cancer, and women's health feature among Clarivate's annual round-up of 11 Drugs to Watch this year, but two of them far outstrip the others in sales ...

The city of Springfield is following in the steps of other large employers in filing suit against manufacturers of diabetes ...

A common diabetes medication does not help people with peripheral artery disease (PAD) and without diabetes walk farther, ...

Powerful new weight-loss medications are in the works to treat obesity. Doctors explain why more options are needed and the ...

Novo Nordisk and Eli Lilly have dominated the market until now, but this year is set to bring oral drugs, generics, and a ...

Pharmaceutical companies have raised prices on hundreds of drugs so far this month despite federal efforts to rein in drug ...

All 16 drug companies that inked deals with the Trump administration over the past few months still raised some of their ...

Delaware is the latest state to accuse pharmaceutical manufactures of jacking up insulin prices, even as the cost to produce diabetes medications has decreased.

Jardiance is the brand name for empagliflozin, an SGLT2 inhibitor used in adults with type 2 diabetes, chronic kidney disease ...

Every January, pharmaceutical companies increase the prices of hundreds of drugs. This year there's a disconnect between the ...